Randhawa Simrat bought DNTH
September 1, 2026 · Form 4 insider transaction
Randhawa Simrat bought 6,249 shares of Dianthus Therapeutics, Inc. at $21.77 per share, a transaction worth $136.0K. The trade was recorded as option exercise under a pre-scheduled Rule 10b5-1 plan and disclosed on an SEC Form 4, filed 2 days after the transaction.
Direction
Acquired (buy-side)
Shares
6,249
Price
$21.77
Total value
$136.0K
InsiderRandhawa Simrat
RoleOfficer
SecurityCommon Stock
Transaction codeM: Option exercise
Transaction dateSeptember 1, 2026
Filing dateSeptember 3, 2026
Shares owned after17,749
OwnershipDirect
10b5-1 planYes
AmendedNo
Footnotes
This transaction was executed pursuant to a Rule 10b5-1 trading plan adopted on August 14, 2025.